We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00735995
First Posted: August 15, 2008
Last Update Posted: April 14, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
The Research Council of Norway
Information provided by (Responsible Party):
Simon-Peter Neumer, Regionsenter for barn og unges psykiske helse
  Purpose
The purpose of this study is to assess the effectiveness of a cognitive-behavioral intervention for children aged 7 to 12 years with anxiety disorders who are referred to ordinary community clinics. The treatment will be conducted as individual therapy or group therapy.

Condition Intervention Phase
Separation Anxiety Disorder Social Phobia Generalized Anxiety Disorder Behavioral: Cognitive behavioral therapy (individual) Behavioral: Cognitive behavioral therapy (group) Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effectiveness of Group and Individual Treatment of Childhood Anxiety Disorders in Community Clinics. A Randomized Controlled Trial.

Resource links provided by NLM:


Further study details as provided by Simon-Peter Neumer, Regionsenter for barn og unges psykiske helse:

Primary Outcome Measures:
  • Status of primary anxiety disorder at inclusion based on the ADIS interview schedule with parents and youth [ Time Frame: post-treatment and 2 year follow-up ]

Secondary Outcome Measures:
  • Symptom score on the MASC [ Time Frame: post-treatment and 2 year follow-up ]
  • CGAS [ Time Frame: post-treatment and 2 year follow-up ]

Enrollment: 165
Study Start Date: August 2008
Study Completion Date: December 2013
Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: A
Individual CBT
Behavioral: Cognitive behavioral therapy (individual)
The Coping Cat program, 12 weekly sessions, two additional parent meetings
Experimental: B
Group CBT
Behavioral: Cognitive behavioral therapy (group)
The Coping Cat program, 12 weekly sessions, two additional parent meetings
No Intervention: C
Waiting-list control

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   7 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary diagnosis of separation anxiety disorder, social phobia or generalized anxiety disorder based on the ADIS interview schedule, DSM-IV criteria

Exclusion Criteria:

  • Pervasive Developmental Disorder
  • Psychotic symptoms
  • Intelligence score < 70
  • Use of medications with anxiety reducing effects during treatment
  • Neither parent competent in Norwegian language
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00735995


Locations
Norway
Akershus Universitetssykehus HF
Lorenskog, Norway, 1478
Sykehuset Asker og Baerum, Baerum BUP
Rud, Norway, 1309
Sykehus Telemark Helseforetak, Skien og Porsgrunn BUP
Skien, Norway
Sponsors and Collaborators
Regionsenter for barn og unges psykiske helse
The Research Council of Norway
Investigators
Principal Investigator: Simon-Peter Neumer, dr.philos Regionsenter for barn og unges psykiske helse
  More Information

Publications:
Responsible Party: Simon-Peter Neumer, dr. Simon-Peter Neumer, Regionsenter for barn og unges psykiske helse
ClinicalTrials.gov Identifier: NCT00735995     History of Changes
Other Study ID Numbers: 186036/V50
186036 ( Other Grant/Funding Number: Norwegian Research Council )
First Submitted: August 13, 2008
First Posted: August 15, 2008
Last Update Posted: April 14, 2014
Last Verified: April 2014

Additional relevant MeSH terms:
Disease
Anxiety Disorders
Phobic Disorders
Anxiety, Separation
Mental Disorders
Pathologic Processes
Neurodevelopmental Disorders